Sep 13, 2021 10:06AM
Jun 24, 2021 08:30AM
Jun 1, 2021 02:23PM
May 20, 2021 08:00AM
May 17, 2021 03:58PM
May 10, 2021 03:58PM
Feb 23, 2021 02:07PM Silver Mountain Mines Executes Definitive Agreement with Nevgold To Create A Strong Diversified Exploration and Development Company
Jan 19, 2021 10:37AM
Oct 27, 2020 09:00AM
Oct 15, 2020 09:30AM
Oct 5, 2020 08:00AM
Aug 5, 2020 08:30AM
Aug 4, 2020 05:41PM
Jul 6, 2020 08:00AM Sunovion Announces Topline Results from Global Phase 2 Study of SEP-4199 in Patients with Bipolar I Depression
Jun 15, 2020 08:00AM
May 21, 2020 06:13PM
May 13, 2020 08:03AM
Apr 15, 2020 05:04PM
Dec 30, 2019 08:30AM
Dec 30, 2019 07:00AM
Dec 20, 2019 08:00AM Sunovion Announces FDA Filing Acceptance of Resubmitted New Drug Application for Apomorphine Sublingual Film
Dec 12, 2019 08:00AM
Dec 9, 2019 11:00AM
Nov 22, 2019 09:00AM
Oct 31, 2019 09:29AM
Oct 31, 2019 09:29AM
Oct 31, 2019 09:20AM
Sep 27, 2019 08:00AM Sunovion and PsychoGenics Initiate DIAMOND Phase 3 Clinical Studies for SEP-363856 in the Treatment of Adults and Adolescents with Schizophrenia
Sep 6, 2019 09:00AM
Sep 6, 2019 03:01AM
Sep 5, 2019 10:40PM
Jul 30, 2019 08:00AM
May 10, 2019 08:00AM
May 2, 2019 08:00AM
May 1, 2019 08:00AM Sunovion to Present Data on LONHALA® MAGNAIR® Inhalation Solution and COPD at the American Thoracic Society International Conference 2019
Mar 6, 2019 03:00PM
Jan 30, 2019 10:15PM
Dec 13, 2018 08:00AM
Sep 19, 2018 08:00AM
Sep 19, 2018 08:00AM
Sep 12, 2018 08:00AM
Aug 31, 2018 09:30AM FDA Issues a Complete Response Letter for New Drug Application for Dasotraline for the Treatment of ADHD
Jul 25, 2018 08:00AM
Jun 27, 2018 02:30PM
Jun 23, 2018 09:00AM
Jun 12, 2018 05:00PM
May 16, 2018 08:23AM
May 2, 2018 08:00AM
Apr 20, 2018 11:34AM Sunovion Announces Health Canada Approval of Latuda® (lurasidone HCl) to Treat Adolescents (13 to 17 years of age) with Bipolar Depression
Apr 3, 2018 08:00AM

1,157,743 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All